2270.0000 11.00 (0.49%)
NSE Aug 06, 2026 15:31 PM
Volume: 556.3K
 

2270.00
0.49%
Deven Choksey
We expect the company to grow its Revenue/EBITDA/PAT at a CAGR of 16.8% / 86.1% / 111.8% for the period of FY26-FY28.
ICICI Securities Limited upgraded Glenmark Pharmaceuticals Ltd. to Hold with a price target of 2100.0 on 04 Aug, 2026.
More from Glenmark Pharmaceuticals Ltd.
Recommended